Management of community-acquired respiratory tract infections

被引：2

作者：

Remington, JS ^{[1
]}

机构：

[1] Stanford Univ, Med Ctr, Sch Med, Dept Med,Div Infect Dis & Geog Med, Stanford, CA 94305 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2004年 / 39卷

关键词：

D O I：

10.1086/421350

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S141 / S141

页数：1

共 50 条

[31] Antibiotics for treating community-acquired lower respiratory tract infections in the elderly
Sanguinetti, CM
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 8 - 10
[32] Changing patterns of etiology and resistance in community-acquired respiratory tract infections
Garau, J
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1998, 7 : S92 - S95
[33] Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review
Fogarty, CM
Buchanan, P
Aubier, M
Baz, M
van Rensburg, D
Rangaraju, M
Nusrat, R
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 (02) : 136 - 147
[34] INFECTIVE PATHOGENS FOR COMMUNITY-ACQUIRED LOWER RESPIRATORY-TRACT INFECTIONS
BAFUNDI, P
RAWJI, M
DEVLIN, R
KASUPSKI, G
CHAN, CK
CLINICAL RESEARCH, 1992, 40 (03): : A763 - A763
[35] Antibiotic resistance in community-acquired respiratory tract infections: current issues
Spach, DH
Black, D
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 81 (04) : 293 - 302
[36] Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections
Nicolau, DP
AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (12): : S381 - S388
[37] Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections
Rocha, RT
Awad, CE
Ali, A
Matyas, R
Vital, ACC
Silva, COS
Dainesi, SM
Salazar, MS
Nakatani, J
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (06) : 433 - 436
[38] Surveillance of resistance in bacteria causing community-acquired respiratory tract infections
Felmingham, D
Feldman, C
Hryniewicz, W
Klugman, K
Kohno, S
Low, DE
Mendes, C
Rodloff, AC
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 : 12 - 42
[39] What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections?
Momméja-Marin, H
Carbon, C
DRUGS, 1999, 57 (06) : 851 - 853
[40] EPIDEMIOLOGIC FEATURES AND CHEMOTHERAPY OF COMMUNITY-ACQUIRED RESPIRATORY-TRACT INFECTIONS
FINCH, RG
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 : 53 - 61

← 1 2 3 4 5 →